Form 4 for BGMS Bio Green Med Solution, Inc.
Accepted 2023-07-03 00:00:00 ET · period of report 2023-06-30 · accession 0001104659-23-077650 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-03 | 2023-06-30 | BGMS | SCHWARTZ BRIAN | Dir | A - Grant | $0.00 | +21.2K | 40.6K | +109% | $0 |
| D | 2023-07-03 | 2023-06-30 | BGMS | SCHWARTZ BRIAN | Dir | A - Grant | $0.00 | +42.4K | 42.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-30 | A | A | 21,219 | $0.00 | 40,602 | D | — | — | (F1) The reporting person received an award of 21,219 restricted stock units on June 30, 2023, which shall vest in full on June 30, 2024. (F2) These securities were granted to Dr. Schwartz for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc. |
| 2 | Derivative | Stock Option (right to buy) | 2023-06-30 | A | A | 42,438 | $0.00 | 42,438 | D | $0.59 · 2024-06-30 to 2033-06-30 | 42,438 Common Stock | (F2) These securities were granted to Dr. Schwartz for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc. |